Members oftwo unrelated families with type I hereditary angioneurotic edema (HANE) were found to have elevated levels of C1 inhibitor (CIINH) mRNA. DNA sequence analysis of PCR-amplified monocyte C1INH mRNA revealed normal and mutant transcripts, as expected in this disorder that occurs in heterozygous individuals. Single base mutations near the 3' end of the coding sequence were identified in affected members of each family. One mutation consisted of insertion of an adenosine at position 1304 which created a premature termination codon (TAA), whereas the second consisted of deletion of the thymidine at position 1298 which created a premature termination codon (TGA) 23 nucleotides downstream. These mutations are -250 nucleotides upstream of the natural termination codon. Nuclear run-off experiments in one kindred revealed no difference in transcription rates of the C1INH gene between the patients and normals. C1INH mRNA half-life experiments were not technically feasible because of the prolonged half-life of the normal transcript. Dideoxynucleotide primer extension experiments allowed the differentiation of the normal and mutant transcripts. These studies showed that the mutant transcript was not decreased relative to the normal, and this therefore was at least partially responsible for the C1INH mRNA elevation. This elevation may be due to the decreased catabolism of the mutant transcript. (J. Clin. Invest. 1991. 88:755-759.)
Introduction
C1INH inhibitor (CIINH)' is a serine proteinase inhibitor that plays a central role in the regulation of both the classical complement pathway and the contact activation pathway of the intrinsic coagulation and kinin-forming systems (1) . The C I INH gene has been localized to chromosome 1 1; it is -17 1 . Abbreviations used in this paper: CIINH, Cl inhibitor; HANE, hereditary angioneurotic edema; PCR, polymerase chain reaction; RFLP, restriction fragment length polymorphism.
kb long with a coding region of -1,800 bp (2) (3) (4) . It consists of eight exons interrupted by introns that contain a high density of repetitive DNA sequences (Alu repeats), thus making the Cl INH gene susceptible to rearrangements (4) . Inherited deficiency of Cl INH is known as hereditary angioneurotic edema (HANE). The disease is transmitted as an autosomal dominant trait (5) . Individuals with HANE, at the molecular level, are heterozygous for defects within the Cl INH gene. The main clinical feature of the disease is localized, recurrent, acute attacks ofedema ofthe skin and mucosa (6) . Acute attacks, especially of life-threatening laryngeal edema, can be prevented with androgen therapy or reversed with C1INH concentrate (7, 8) . There are two phenotypic variants of the disease. Type 1 HANE is characterized by low antigenic and functional plasma levels (-5-30% of the normals) of a normal C1INH protein.
These patients represent the majority of HANE patients (-85%). Type 2 HANE is characterized by the presence of normal or elevated antigenic levels of a dysfunctional mutant protein together with reduced levels of the functional protein (9, 10) . The available data suggest that a variety of mutations are responsible for C1INH deficiency. Restriction fragment length polymorphism (RFLP) of the C1INH gene has been demonstrated in a minority of patients of both types (10-15% of kindred) (1 1, 12). All RFLPs described in type I HANE have resulted from partial deletions or insertions within the C1INH gene and these all have involved Alu repetitive DNA (13, 14) . Other mutations that may result in type I HANE have not been defined at the molecular level. Single base substitutions at the reactive center coding region have been shown to be the most common abnormality in type 2 HANE (15, 16, Aulak, K. S., personal communication), although at least two other mutations, one a single base change and the other a codon deletion, have been observed (17, 18 ).
Studies at the mRNA level have demonstrated that levels of C I INH mRNA are -50% of normal in the majority of type I HANE patients, as might be expected with transcription of only one allele (19, 20) . Some patients with deletions transcribe a small mRNA, which is present together with the normal transcript (14, 19, 21) . We also have identified two kindred with elevated quantities of a normal size C1INH message, despite the low antigenic and functional plasma levels of C1 INH (22) . In this study, we investigated the molecular genetic defects responsible for this abnormality in these two type 1 HANE families. Sequence analysis in each revealed single base mutations leading to the introduction of premature termination codons located near the 3' end of the gene. The abnormal transcript was increased in concentration in one family and was present in quantities similar to the normal transcript in the other. The fact that the transcription rate does not show any variation compared with the normal suggests that the abnormal message is relatively stable despite the presence of a premature stop codon.
Methods
Patients. We have investigated two affected members from each oftwo different type 1 HANE families. All affected members of each kindred had clinical histories of recurrent episodes of angioedema. Multiple measurements ofCIINH levels in all affected individuals were always decreased, both by functional and immunochemical measurement. No RFLPs were demonstrated in these subjects (1 1 Nuclear run-off. Nuclear run-off experiments were performed essentially as described (29) (25 mM Tris-HCI, pH 8, 12.5 mM MgCI2, 750 mM KCI, and 1.25 mM each of dGTP, dCTP, and dATP), and 100 MACi 32P-UTP (6, 
Results
Northern blot analysis. Northern blot analysis demonstrated the presence of elevated levels of normal sized specific C INH mRNA in the patients from the two type 1 kindred analyzed (Fig. 1) (Fig. 4, lane 3) , 11 nucleotides in the allele with the deletion (Fig. 4, lane 2) , and 13 nucleotides in the allele with an insertion (Fig. 4, lane 1) . This experiment allowed the demonstration that the abnormal transcript is present in concentrations equal to (family 1, Fig. 4, lane 1) or greater than (family 2, Fig. 4, lane 2) the concentration of the normal transcript.
Half-life and nuclear run-off. To analyze the mechanisms leading to the increased level of mRNA in these patients, we attempted to investigate both transcription rate and RNA stability. However, the RNA stability experiments were not reliable because of the long half-life (over 16 h) of the normal CIINH mRNA. The data beyond 16 h were inaccurate because of spontaneous mortality ofthe cells treated with actinomycin D. Nuclear run-off assays revealed no difference in the transcription rate between two different normal individuals and a member offamily 1 (Fig. 5) , thus indicating that the increase of total CIINH mRNA in this family was not due to an increased transcription rate. No member offamily 2 was available for this study. 
Discussion
The mutations leading to C1INH deficiency in the two described families with type 1 HANE were single base substitutions that resulted in the introduction of premature termination codons in the last exon ofthe C1INH gene. Northern blot analysis showed elevated levels of ClINH-specific mRNA in these subjects despite the low antigenic and functional levels of C1INH protein in plasma (Fig. 1 (19, 20, 32) . Some patients with partial deletions reveal two transcripts: a normal mRNA present at concentrations 50% of normal; and a smaller transcript ofthe partially deleted allele which is at similar or lower concentrations. In the two families described here, the dideoxynucleotide primer extension studies prove that both alleles are, in fact, transcribed. In one family, the normal and abnormal transcripts appear to be similar in concentration (Fig. 4, lane 1 quired to determine whether in these patients there is a relationship between translation and mRNA levels. 2 and 3) . The ClINH mRNA relative to control transcripts was not increased over the normals.
other, the mutant transcript is present in larger quantities (Fig.  4, lane 2) . Thus, the elevated mRNA levels are, at least partially, a result of an increase in concentration of the abnormal transcript. It was not possible to detect any smaller CIINH protein in sera from these patients after immunoprecipitation
with anti-C lINH antiserum (data not shown). Only CIINH of normal size was observed. Therefore, it is not known whether the abnormal mRNA is not translated or if it is translated into an unstable truncated CIINH protein.
There is growing evidence that nonsense mutations are not always associated with decreased levels of steady-state mRNA, as previously reported (28, [33] [34] [35] . Normal levels of mRNA have been shown for the LDL receptor (36) , for the beta-globin chain (37) and for apolipoprotein CII (38) in patients with nonsense mutations of these genes. Similar findings were reported for the dihydrofolate reductase gene in which nonsense mutations were artificially introduced at various points in the gene sequence (39) . These data all indicate that the closer a mutation is to the 3' end of a gene the higher the levels of abnormal mRNA. The mechanisms leading to alterations in mRNA levels with premature termination codons are not clearly understood. They may involve differences in transcription rate, in the efficiency of processing and transport to the cytoplasm or in the stability of intracellular mRNA. In these C IINH-deficient patients, no difference in transcription rate was found compared with normal, as shown by the nuclear run-off experiments. Because no abnormality was detected in the cDNA sequence at the splice junctions, and because the mutations are located within the last exon, RNA splicing very likely is normal. There is, therefore, no evidence that alterations in RNA processing are present in these patients. Because the half-life of the normal CIINH mRNA is so long, it was not technically possible to show a prolonged half-life of the abnormal transcripts. However, it remains possible that elevated levels of the abnormal transcripts may be due to enhanced stability compared with the normal transcript. The mechanisms leading to increased stability are not completely understood. There appear to be many different determinants involved in the regulation of mRNA stability, including structures located near the 3' end of the mRNA (such as the poly(A) tail), and modification of mRNA secondary structures (40) (41) (42) (43) . The length of the poly(A) sequence was the same in the abnormal message from the patients described here as in the normal (data not shown). Analysis of the mRNA sequences from these patients using PC/Gene (Intelligenetics, Inc., Mountain View, CA) revealed no apparent difference from the normal CIINH mRNA secondary structure. It also has been suggested that a block in protein elongation per se may be responsible for a longer halflife of some mRNA species (44). Further studies will be re-
